江苏常青树新材料科技股份有限公司 证券代码：603125 证券简称：常青科技 公告编号：2023-019 江苏常青树新材料科技股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 5 月 17 日（周三）上午 10:00-11:30 会议召开地点：上海证券交易所上证路演中心 （http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频录播和网络互动 投资者可于 2023 年 05 月 10 日(周三)至 05 月 16 日(周二)16:00 前登录 上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 securities@cqs-hm.com进行提问。公司将在说明会上对投资者普遍关注的问题 进行回答。 江苏常青树新材料科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 29 日发布公司 2022 年年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营成果、财务状况，公司计 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥237,104,283.89, representing a year-on-year increase of 10.26%[3] - The net profit attributable to shareholders was ¥46,278,194.85, with a slight increase of 0.36% compared to the same period last year[3] - The basic and diluted earnings per share remained at ¥0.32, unchanged from the previous year[3] - The total comprehensive income for the period was ¥46,278,194.85, slightly up from ¥46,112,884.99 in the previous year[17] Cash Flow - The net cash flow from operating activities reached ¥57,256,098.62, showing a significant increase of 658.99% year-on-year[3] - The company's net cash flow from operating activities for Q1 2023 was ¥57,256,098.62, a significant increase from ¥7,543,747.23 in Q1 2022, representing a growth of approximately 658%[19] - Cash received from sales of goods and services reached ¥252,519,880.63 in Q1 2023, compared to ¥176,991,619.88 in Q1 2022, indicating a year-over-year increase of about 42.5%[19] - The net cash flow from investing activities was -¥6,014,609.35, worsening from -¥4,279,803.99 in the same period last year[20] - The net cash flow from financing activities was -¥13,397,375.01, compared to a positive net cash flow of ¥2,508,237.85 in Q1 2022[20] - The cash inflow from operating activities totaled ¥255,295,192.04, compared to ¥178,214,036.54 in the previous year, showing an increase of approximately 43.3%[19] - The cash and cash equivalents at the end of Q1 2023 totaled ¥250,372,530.48, up from ¥122,233,263.43 at the end of Q1 2022, reflecting a growth of approximately 104.8%[20] - The company incurred cash outflows of ¥15,365,473.65 for taxes in Q1 2023, compared to ¥9,687,689.67 in Q1 2022, marking an increase of about 58.6%[19] - The company experienced a negative impact of -¥222,706.57 from foreign exchange rate changes on cash and cash equivalents[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥978,392,116.07, reflecting a 0.49% increase from the end of the previous year[4] - The total current assets as of March 31, 2023, amounted to RMB 724,458,221.19, a slight increase from RMB 715,653,395.29 at the end of 2022[12] - The total liabilities decreased to RMB 93,913,562.84 as of March 31, 2023, down from RMB 136,851,856.07 at the end of 2022, indicating a reduction of 31.3%[13] - The company's cash and cash equivalents increased to RMB 250,566,004.53 from RMB 212,857,846.00, representing a growth of 17.7%[11] - The inventory level rose to RMB 108,776,493.01 as of March 31, 2023, compared to RMB 99,180,420.43 at the end of 2022, an increase of 9.6%[12] - The total equity increased to RMB 884,478,553.23 as of March 31, 2023, from RMB 836,815,593.29 at the end of 2022, reflecting a growth of 5.7%[13] - The equity attributable to shareholders increased by 5.70% to ¥884,478,553.23 compared to the end of the previous year[4] - The company's short-term borrowings significantly decreased to RMB 500,565.28 from RMB 13,317,578.61, indicating a reduction of 96.2%[13] Research and Development - Research and development expenses surged by 144.31% due to new projects initiated in Q1 2023[6] - Research and development expenses increased significantly to RMB 9,234,747.96 in Q1 2023, compared to RMB 3,779,955.91 in Q1 2022, marking a rise of 144.5%[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 83,871[8] - The weighted average return on equity decreased by 20.75 percentage points to 5.36%[3] - The company received government subsidies amounting to ¥235,272.23 during the reporting period[5] Expenses - The company reported a decrease in sales expenses to RMB 2,534,625.91 in Q1 2023 from RMB 3,081,431.32 in Q1 2022, a decline of 17.8%[16]

Financial Performance - In 2022, the company achieved operating revenue of CNY 963.61 million, a year-on-year increase of 27.07%[26]. - The net profit attributable to shareholders reached CNY 190.65 million, reflecting a growth of 32.73% compared to the previous year[26]. - The net profit after deducting non-recurring gains and losses was CNY 190.06 million, up 31.33% year-on-year[26]. - The company's total assets at the end of 2022 amounted to CNY 973.67 million, an increase of 21.32% from the previous year[26]. - The basic earnings per share for 2022 was CNY 1.32, representing a 33.33% increase from CNY 0.99 in 2021[27]. - The gross profit for 2022 was CNY 295.59 million, with a significant increase of CNY 68.16 million, or 29.98% from the previous year[74]. - The main business revenue was CNY 962.63 million, with a growth of 27.10% compared to the previous year[74]. - The company reported a revenue increase of 15% year-over-year, reaching $500 million in Q4 2022[176]. R&D and Innovation - The company focused on R&D investment, emphasizing innovation in high polymer new materials and enhancing management capabilities[34]. - The company has strengthened partnerships with research institutions and universities to enhance R&D capabilities and accelerate new product development[34]. - The company’s R&D expenses increased by 223.39% to CNY 315.78 million, reflecting a strong commitment to product innovation[81]. - The company has developed multiple key patents and technologies, enhancing its competitive position in the specialty monomers and additives market[65]. - The company holds 69 patents, including 8 invention patents, reflecting its commitment to technological innovation[70]. - The company is actively involved in research and development of new products and technologies to meet market demands[109]. - The company has developed a one-step synthesis technology for divinylbenzene, significantly improving product quality and enabling the production of high-purity isomers, which is crucial for new polymer materials[141]. Market Position and Strategy - The company operates in the high polymer new materials industry, which is currently in a robust growth phase without significant cyclical characteristics[46]. - The company aims to align with national policies promoting high-quality development in the petrochemical industry, enhancing its competitive capabilities[47]. - The company has achieved multiple breakthroughs in key production technologies and processes for specialty monomers and additives, positioning itself as a significant player in the high-performance polymer materials sector[140]. - The company aims to enhance its competitive edge by focusing on high-end specialty chemicals and advanced materials[107]. - The company is positioned to benefit from industry policies promoting innovation and transformation in the chemical sector[106]. Corporate Governance - The board of directors has confirmed that all members attended the board meeting, ensuring proper governance and decision-making[4]. - The company has received a standard unqualified audit report from its accounting firm, ensuring the accuracy and completeness of the financial report[5]. - The company has not faced any issues with a majority of directors being unable to guarantee the authenticity of the annual report[10]. - The company held 3 supervisory board meetings throughout the year, ensuring compliance with legal and regulatory requirements[166]. - Independent directors accounted for over one-third of the board, actively participating in meetings and providing positive suggestions on management and strategic direction[168]. Risk Management - The company has outlined potential risks in its future plans and strategies, advising investors to be aware of investment risks[7]. - The company faces risks from industry regulation changes, market competition, raw material price fluctuations, safety production, environmental protection, and exchange rate volatility, which could adversely affect its operations and profitability[155][156][158][159][160][161]. - The company has strengthened its internal control system to ensure compliance, asset security, and accurate financial reporting, improving operational efficiency[38]. Production and Operations - The company reported a net cash flow from operating activities of CNY 113.62 million, a slight decrease of 3.57% from the previous year[26]. - The company plans to continue optimizing production processes and improving operational efficiency through advanced management practices and technology integration[36]. - The company’s production efficiency is high, with special monomers produced using a continuous production method, while special additives are produced in batches, allowing for flexibility[116]. - The company employs a "production based on sales" model, aligning production plans with market demand and maintaining safety stock[115]. Shareholder Returns - The company plans to distribute a cash dividend of 0.9 RMB per 10 shares, totaling 17,329,500 RMB based on a total share capital of 192,550,000 shares[6]. - The profit distribution plan was approved by the board and will be presented to the shareholders' meeting, ensuring the protection of minority shareholders' rights[197]. - The board of directors approved a dividend payout of $0.50 per share, reflecting a commitment to returning value to shareholders[176].

股票简称：常青科技 股票代码：603125 江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） （镇江新区青龙山路 3 号） 首次公开发行股票主板上市公告书 保荐人（主承销商） （上海市静安区新闸路 1508 号） 二〇二三年四月七日 江苏常青树新材料科技股份有限公司 上市公告书 特别提示 江苏常青树新材料科技股份有限公司（以下简称"常青科技"、"本公司"、 "公司"、"发行人"）股票将于 2023 年 4 月 10 日在上海证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在新 股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 1 江苏常青树新材料科技股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明与提示 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真实、 准确、完整，承诺上市公告书不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 上海证券交易所、有关政府机关对本公司股票上市及有关事项的意见，均不 表明对 ...

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） 声明 （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股说明书 保荐人（主承销商） （上海市静安区新闸路 1508 号） 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | | | | | --- | --- | --- | --- | --- | --- | | 发行股数 | 本次向社会公众公开发行 股）股票； | | | | 4,814.00 万股人民币 ...

江苏常青树新材料科技股份有限公司 首次公开发行股票并在主板上市 发行结果公告 保荐人(主承销商)：光大证券股份有限公司 本次发行的网上、网下认购款项缴纳工作已于 2023 年 3 月 30 日（T+2 日） 结束。 江苏常青树新材料科技股份有限公司（以下简称"常青科技"、"发行人" 或"公司"）首次公开发行人民币普通股（A 股）并在主板上市（以下简称"本 次发行"）的申请已经上海证券交易所（以下简称"上交所"）上市审核委员会审 议通过，并已经中国证券监督管理委员会证监许可[2023]583 号文同意注册。 本次发行的保荐人（主承销商）为光大证券股份有限公司（以下简称"光大 证券"或"保荐人（主承销商）"）。发行人的股票简称为"常青科技"，扩位 简称为"江苏常青树科技"股票代码为"603125"。 本次发行采用网下向符合条件的投资者询价配售（以下简称"网下发行"） 和网上向持有上海市场非限售 A 股股份及非限售存托凭证市值的社会公众投资 者定价发行（以下简称"网上发行"）相结合的方式进行。本次发行不安排战略 配售。 发行人与保荐人（主承销商）根据初步询价结果，综合发行人所处行业、市 场情况、可比公司估值水平、募 ...

江苏常青树新材料科技股份有限公司 首次公开发行股票并在主板上市 发行公告 光大证券股份有限公司（以下简称"光大证券"、"主承销商"或"保荐人（主 承销商）"）担任本次发行的保荐人（主承销商）。 本次发行采用网下向符合条件的网下投资者询价配售（以下简称"网下发行"） 与网上向持有上海市场非限售 A 股股份和非限售存托凭证市值的社会公众投资 者定价发行（以下简称"网上发行"）相结合的方式进行。本次发行的初步询价 及网上、网下发行由保荐人（主承销商）光大证券负责组织实施。本次发行的初 步询价和网下申购均通过上交所互联网交易平台（IPO 网下询价申购）（以下简 称"互联网交易平台"）进行，网上发行通过上交所交易系统进行，请投资者认 1 真阅读本公告。关于初步询价和网下发行电子化的详细内容，请查阅上交所网站 （www.sse.com.cn）公布的《网下发行实施细则》等相关规定。 保荐人(主承销商)：光大证券股份有限公司 重要提示 江苏常青树新材料科技股份有限公司（以下简称"常青科技"、"发行人"或 "公司"）根据中国证券监督管理委员会（以下简称"中国证监会"、"证监会"） 颁布的《证券发行与承销管理办法》（证监会令〔第 ...

保荐人（主承销商）：光大证券股份有限公司 扫描二维码查阅公告全文 江苏常青树新材料科技股份有限公司（以下简称"常青科技"、"发行人"或"公 司"）首次公开发行股票并在主板上市的申请已经上海证券交易所（以下简称"上 交所"）上市审核委员会审议通过，并已经中国证券监督管理委员会（以下简称"中 国证监会"）证监许可〔2023〕583 号文同意注册。《江苏常青树新材料科技股份 有限公司首次公开发行股票并在主板上市招股意向书》及附录在上海证券交易所 网站（http://www.sse.com.cn/）和符合中国证监会规定条件网站（中证网， http://www.cs.com.cn/；中国证券网，http://www.cnstock.com/；证券时报网， http://www.stcn.com/；证券日报网，http://www.zqrb.cn/）披露，并置备于发行人、 上交所、本次发行保荐人（主承销商）光大证券股份有限公司的住所，供公众查 阅。 江苏常青树新材料科技股份有限公司 首次公开发行股票并在主板上市 招股意向书提示性公告 保荐人（主承销商）：光大证券股份有限公司 2023 年 3 月 20 日 2 （本页无正 ...

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股意向书 保荐人（主承销商） （上海市静安区新闸路 1508 号） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | | | --- | --- | --- | --- | | 发行股数 | 本次拟向社会公众公开发行 4,814.00 股）股票； | | 万股人民币普通股（A | | | 本次发行全部为 ...

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股说明书 （注册稿） 声明：本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招股说明书 不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当以正式公告的招股说明书 全文作为作出投资决定的依据。 保荐机构（主承销商） （上海市静安区新闸路 1508 号） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通 ...